BioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI
admin By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the…
Read MoreResearch/Development
Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreGSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients…
Read MoreApple reportedly pauses hiring for many roles, joining Amazon in belt-tightening
Apple Inc. reportedly has put a pause on hiring for positions that aren’t in research…
Read MoreInvest in stocks that return cash to shareholders in an economic slowdown, says Goldman
In an economic slowdown, investors should own stocks that return cash to shareholders, rather than…
Read MoreOpinion: China’s economy is rotting from the head
BOSTON (Project Syndicate)—China highlights a long-debated question about economic development: Can a top-down autocracy outperform…
Read MoreNew York has the most expensive rents in the U.S. This city is No. 2…
Rents in Boston are soaring past housing costs in famously pricey California cities like San…
Read MoreAstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with…
Read MoreNovartis hemoglobinuria trial meets two primary endpoints
Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug to…
Read More
Opinion: Opinion: Global cooperation is not necessary to fight climate change
PROVIDENCE, R.I. (Project Syndicate)—This week’s United Nations Climate Change Conference (COP27) in Egypt highlights the…
Read More